| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $144K | +32.1% |
| Cost of Revenue | $5K | — |
| R&D Expense | $5.0M | -8.6% |
| SG&A Expense | $7.7M | -20.3% |
| Operating Income | -$12.6M | +16.4% |
| Income Tax | $2K | +0.0% |
| Net Income | -$2.5M | +83.0% |
| EPS (Basic) | -$1.70 | -6.2% |
| EPS (Diluted) | -$1.70 |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.3M | +289.9% |
| Accounts Receivable | $30K | -9.1% |
| Inventory | $0 | -100.0% |
| Current Assets | $12.1M | +208.2% |
| Total Assets | $14.7M | +130.7% |
| Current Liabilities | $3.7M | +100.9% |
| Total Liabilities | $4.2M | +51.3% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.5M | +35.4% |
| Capital Expenditures | $13K | -69.0% |
| Investing Cash Flow | $9.0M | +1006.0% |
| Financing Cash Flow | $8.8M | +515.7% |
| Free Cash Flow | -$9.5M | +35.5% |
| -6.2% |
| Stockholders' Equity |
| $10.5M |
| +191.4% |